Education
About Us
Working with TipRanks
Follow Us
LENZ Therapeutics (LENZ)
NASDAQ:LENZ
LENZ Therapeutics (LENZ) Ownership Overview
37.88% Insiders
5.81% Mutual Funds
0.16% Other Institutional Investors
7.61% ETFs
48.55% Public Companies and
Individual Investors
The ownership structure of LENZ Therapeutics (LENZ) stock is a mix of institutional, retail, and individual investors. Approximately 13.58% of the company’s stock is owned by Institutional Investors, 37.88% is owned by Insiders, and 48.55% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| May 15, 2024 | xxxxxxxxxxxxx | $49988 | |
| May 14, 2024 | James W Mccollum Director | xxxxxxxxxxxxx | $500999 |
| Mar 25, 2024 | Ra Capital Management, Llc Director, >10% Owner | xxxxxxxxxxxxx | $15000075 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $259 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,542,150 | Insider | 16.52% | 115,597,718 | |
| 4,178,823 | Institution | 15.20% | 106,351,045 | |
| 3,612,211 | Institution | 13.13% | 91,930,770 | |
| 1,882,693 | Insider | 7.40% | 47,914,537 | |
| 3,548,529 | Insider | 6.10% | 90,310,063 | |
| 1,389,510 | Insider | 5.05% | 35,363,030 | |
| 1,139,546 | Institution | 4.14% | 29,001,446 | |
| 1,051,693 | Institution | 3.82% | 26,765,587 | |
| 693,786 | Institution | 2.52% | 17,656,854 | |
| 620,599 | Insider | 2.26% | 15,794,245 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,051,693 | Institution | 3.82% | 26,765,587 | |
| 160,738 | Institution | 0.58% | 4,090,782 | |
| 142,450 | Institution | 0.52% | 3,625,353 | |
| 68,630 | Institution | 0.25% | 1,746,634 | |
| 55,647 | Institution | 0.20% | 1,416,216 | |
| 37,132 | Institution | 0.14% | 945,009 | |
| 18,406 | Institution | 0.07% | 468,433 | |
| 15,893 | Institution | 0.06% | 404,477 | |
| 10,606 | Institution | 0.04% | 269,923 | |
| 10,466 | Institution | 0.04% | 266,360 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 811,477 | Institution | 2.95% | 17,714,543 | |
| 345,299 | Institution | 1.26% | 8,787,860 | |
| 244,834 | Institution | 0.89% | 5,344,726 | |
| 185,194 | Institution | 0.67% | 4,583,552 | |
| 135,882 | Institution | 0.49% | 3,458,197 | |
| 118,217 | Institution | 0.43% | 3,008,623 | |
| 74,633 | Institution | 0.27% | 1,847,167 | |
| 57,919 | Institution | 0.21% | 1,264,372 | |
| 29,969 | Institution | 0.11% | 762,711 | |
| 28,187 | Institution | 0.10% | 717,359 |
FAQ
Who Owns LENZ Therapeutics (LENZ)?
According to the latest TipRanks data, approximately 0.16% of the company's stock is held by institutional investors, 37.88% is held by insiders, and 48.55% is held by retail investors.
What percentage of LENZ Therapeutics (LENZ) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.16% of LENZ Therapeutics (LENZ) stock is held by institutional investors.
What percentage of LENZ Therapeutics (LENZ) stock is held by retail investors?
According to the latest TipRanks data, approximately 48.55% of LENZ Therapeutics (LENZ) stock is held by retail investors.
Who owns the most shares of LENZ Therapeutics (LENZ)?
Versant Venture Capital VI, L.P. owns the most shares of LENZ Therapeutics (LENZ).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.